Evidence map›Paper›PMID 19154569›Full record

ArticleBMC evolutionary biology2009

A P2X receptor from the tardigrade species Hypsibius dujardini with fast kinetics and sensitivity to zinc and copper.

Selvan Bavan, Volko A Straub, Mark L Blaxter, Steven J Ennion

Open access · goldAbstract read
In one paragraph

Article in BMC evolutionary biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. The Endocannabinoid System in Caenorhabditis elegans.Reviews of physiology, biochemistry and pharmacology · 2023
    Review
  2. Article
  3. Article
  4. Review
  5. Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signalling.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Review
  6. Article
  7. No evidence for extensive horizontal gene transfer in the genome of the tardigrade Hypsibius dujardini.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. P2X receptor homologs in basal fungi.Purinergic signalling · 2012
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. P2X receptors: dawn of the post-structure era.Trends in biochemical sciences · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Selvan BavanDepartment of Cell Physiology and Pharmacology, University of Leicester, Leicester, UK. sb314@le.ac.uk
Volko A Straub
Mark L Blaxter
Steven J Ennion
University of Leicester · GBUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council C19146Wellcome TrustWellcome Trust WT081601MA
6 · The paper itself

Abstract

backgroundOrthologs of the vertebrate ATP gated P2X channels have been identified in Dictyostelium and green algae, demonstrating that the emergence of ionotropic purinergic signalling was an early event in eukaryotic evolution. However, the genomes of a number of animals including Drosophila melanogaster and Caenorhabditis elegans, both members of the Ecdysozoa superphylum, lack P2X-like proteins, whilst other species such as the flatworm Schistosoma mansoni have P2X proteins making it unclear as to what stages in evolution P2X receptors were lost. Here we describe the functional characterisation of a P2X receptor (HdP2X) from the tardigrade Hypsibius dujardini demonstrating that purinergic signalling is preserved in some ecdysozoa.

resultsATP (EC50 approximately 44.5 microM) evoked transient inward currents in HdP2X with millisecond rates of activation and desensitisation. HdP2X is antagonised by pyridoxal-phosphate-6-azophenyl-2',4' disulfonic acid (IC50 15.0 microM) and suramin (IC50 22.6 microM) and zinc and copper inhibit ATP-evoked currents with IC50 values of 62.8 microM and 19.9 microM respectively. Site-directed mutagenesis showed that unlike vertebrate P2X receptors, extracellular histidines do not play a major role in coordinating metal binding in HdP2X. However, H306 was identified as playing a minor role in the actions of copper but not zinc. Ivermectin potentiated responses to ATP with no effect on the rates of current activation or decay.

conclusionThe presence of a P2X receptor in a tardigrade species suggests that both nematodes and arthropods lost their P2X genes independently, as both traditional and molecular phylogenies place the divergence between Nematoda and Arthropoda before their divergence from Tardigrada. The phylogenetic analysis performed in our study also clearly demonstrates that the emergence of the family of seven P2X channels in human and other mammalian species was a relatively recent evolutionary event that occurred subsequent to the split between vertebrates and invertebrates. Furthermore, several characteristics of HdP2X including fast kinetics with low ATP sensitivity, potentiation by ivermectin in a channel with fast kinetics and distinct copper and zinc binding sites not dependent on histidines make HdP2X a useful model for comparative structure-function studies allowing a better understanding of P2X receptors in higher organisms.

Indexed as

Purinergic P2 Receptor AntagonistsAdenosine TriphosphateAmino Acid SequenceAnimalsCopperInvertebratesIvermectinKineticsMolecular Sequence DataOocytesPhylogenyReceptors, Purinergic P2Receptors, Purinergic P2XSequence Homology, Amino AcidXenopusZincAdenosine TriphosphateCopperIvermectinPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2Receptors, Purinergic P2XZinc

Identifiers

PMID19154569
PMCPMC2633282
OpenAlexW2099487859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.